- Report
- April 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- December 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- September 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- June 2025
- 379 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 67 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 590 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 83 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 378 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 212 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 380 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 73 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 265 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 602 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more